These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and tolerability of flunarizine in the prophylaxis of migraine. Centonze V, Tesauro P, Trizio T, Magrone D, Vino M, Macinagrossa G, Campanozzi F, Altomare E, Attolini E, Albano O. Cephalalgia; 1985 May; 5 Suppl 2():165-8. PubMed ID: 3893737 [No Abstract] [Full Text] [Related]
3. Telethermographic investigations in migraine patients before and after flunarizine treatment. Giacovazzo M, Valducci G, Martelletti P, Romiti A, Gallo MF, Valducci M. Cephalalgia; 1985 May; 5 Suppl 2():169-71. PubMed ID: 4016928 [Abstract] [Full Text] [Related]
5. Hormonal and metabolic changes induced by flunarizine therapy: preliminary results. Cortelli P, Santucci M, Righetti F, Pirazzoli P, Cacciari E, Albani F, Baldrati A, De Carolis P, Baruzzi A, Sacquegna T. Cephalalgia; 1985 May; 5 Suppl 2():185-6. PubMed ID: 4016933 [Abstract] [Full Text] [Related]
6. Influence of flunarizine on the altered electronystagmographic (ENG) recordings in migraine. Pini LA, Ferrari A, Guidetti G, Galetti G, Sternieri E. Cephalalgia; 1985 May; 5 Suppl 2():173-5. PubMed ID: 4016930 [Abstract] [Full Text] [Related]
9. The effects of flunarizine in experimental models related to the pathogenesis of migraine. Wauquier A, Ashton D, Marrannes R. Cephalalgia; 1985 May 17; 5 Suppl 2():119-23. PubMed ID: 4016924 [Abstract] [Full Text] [Related]
13. Flunarizine in the treatment of headache with or without neurological symptoms. Nattero G, Savi L, De Lorenzo C. Cephalalgia; 1985 May 17; 5 Suppl 2():141-3. PubMed ID: 3893734 [Abstract] [Full Text] [Related]
14. Effectiveness of flunarizine in altering electronystagmographic patterns in migraine patients: a preliminary report. Pini LA, Ferrari A, Guidetti G, Galetti G, Barbieri L, Sternieri E. Int J Clin Pharmacol Res; 1986 May 17; 6(1):27-32. PubMed ID: 3957502 [Abstract] [Full Text] [Related]
16. [Results of treatment of migraine patients with cinnarizine and flunarizine]. Drillisch C, Girke W. Med Welt; 1980 Dec 19; 31(51-52):1870-2. PubMed ID: 6110158 [No Abstract] [Full Text] [Related]
17. Pupillary and vascular effects of calcium antagonists in migraine. Fanciullacci M, Boccuni M, Pietrini U, Cangi F, Gatto G, Marabini S, Fusco BM. Cephalalgia; 1985 May 19; 5 Suppl 2():181-3. PubMed ID: 4016932 [Abstract] [Full Text] [Related]
19. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine. Amery WK. Headache; 1983 Mar 19; 23(2):70-4. PubMed ID: 6343298 [No Abstract] [Full Text] [Related]
20. Nomenclature for flunarizine, cinnarizine, and lomerizine. Chu MK, Wang SJ. Cephalalgia; 2020 Mar 19; 40(3):321-322. PubMed ID: 31955597 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]